Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

Similar articles for PubMed (Select 22752605)

1.

Differentiation of etiologic agents of bacterial keratitis from presentation characteristics.

Mascarenhas J, Srinivasan M, Chen M, Rajaraman R, Ravindran M, Lalitha P, Oldenburg CE, Ray KJ, Glidden DV, Costanza S, Lietman TM, Acharya NR.

Int Ophthalmol. 2012 Dec;32(6):531-8. doi: 10.1007/s10792-012-9601-x. Epub 2012 Jun 30.

2.

Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.

Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR.

Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):267-72. doi: 10.1167/iovs.11-7840.

3.

Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.

Ray KJ, Prajna L, Srinivasan M, Geetha M, Karpagam R, Glidden D, Oldenburg CE, Sun CQ, McLeod SD, Acharya NR, Lietman TM.

JAMA Ophthalmol. 2013 Mar;131(3):310-3. doi: 10.1001/jamaophthalmol.2013.1718.

4.

Nocardia keratitis: clinical course and effect of corticosteroids.

Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Priya JL, Sy A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Lietman TM, Acharya NR.

Am J Ophthalmol. 2012 Dec;154(6):934-939.e1. doi: 10.1016/j.ajo.2012.06.001. Epub 2012 Sep 5.

5.

The steroids for corneal ulcers trial: study design and baseline characteristics.

Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR; Steroids for Corneal Ulcers Trial Group.

Arch Ophthalmol. 2012 Feb;130(2):151-7. doi: 10.1001/archophthalmol.2011.303. Epub 2011 Oct 10.

6.

Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.

Borkar DS, Fleiszig SM, Leong C, Lalitha P, Srinivasan M, Ghanekar AA, Tam C, Li WY, Zegans ME, McLeod SD, Lietman TM, Acharya NR.

JAMA Ophthalmol. 2013 Feb;131(2):147-53. doi: 10.1001/jamaophthalmol.2013.778.

7.

Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).

Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR; Steroids for Corneal Ulcers Trial Group.

Arch Ophthalmol. 2012 Feb;130(2):143-50. doi: 10.1001/archophthalmol.2011.315. Epub 2011 Oct 10.

8.

The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.

Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, O'Brien KS, Glidden DV, Ray KJ, Oldenburg CE, Zegans ME, Whitcher JP, McLeod SD, Porco TC, Lietman TM, Acharya NR; Steroids for Corneal Ulcers Trial Group.

Am J Ophthalmol. 2014 Feb;157(2):327-333.e3. doi: 10.1016/j.ajo.2013.09.025. Epub 2013 Oct 1.

9.

Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.

Oldenburg CE, Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Borkar DS, Ray KJ, Zegans ME, McLeod SD, Porco TC, Lietman TM, Acharya NR.

Ophthalmic Epidemiol. 2013 Jun;20(3):155-8. doi: 10.3109/09286586.2013.790978. Epub 2013 May 10.

10.

Pneumococcal keratitis: a clinical profile.

Parmar P, Salman A, Kalavathy CM, Jesudasan CA, Thomas PA.

Clin Experiment Ophthalmol. 2003 Feb;31(1):44-7.

PMID:
12580893
11.

Paediatric bacterial keratitis cases in Shanghai: microbiological profile, antibiotic susceptibility and visual outcomes.

Hong J, Chen J, Sun X, Deng SX, Chen L, Gong L, Cao W, Yu X, Xu J.

Eye (Lond). 2012 Dec;26(12):1571-8. doi: 10.1038/eye.2012.210. Epub 2012 Oct 19.

12.

Study of the first contact management profile of cases of infectious keratitis: a hospital-based study.

Vajpayee RB, Dada T, Saxena R, Vajpayee M, Taylor HR, Venkatesh P, Sharma N.

Cornea. 2000 Jan;19(1):52-6.

PMID:
10632009
13.

Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis.

Oldenburg CE, Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Mascarenhas J, Nardone N, Ray KJ, Glidden DV, Acharya NR, Lietman TM.

Invest Ophthalmol Vis Sci. 2013 Feb 28;54(2):1522-6. doi: 10.1167/iovs.12-11246.

15.

Perineural infiltrates in Pseudomonas keratitis.

Robbie SJ, Vega FA, Tint NL, Hau S, Allan B.

J Cataract Refract Surg. 2013 Nov;39(11):1764-7. doi: 10.1016/j.jcrs.2013.08.018.

PMID:
24160385
16.

Orthokeratology associated microbial keratitis.

Shehadeh-Masha'our R, Segev F, Barequet IS, Ton Y, Garzozi HJ.

Eur J Ophthalmol. 2009 Jan-Feb;19(1):133-6.

PMID:
19123161
17.

A clinical microbiological study of corneal ulcer patients at western Gujarat, India.

Somabhai Katara R, Dhanjibhai Patel N, Sinha M.

Acta Med Iran. 2013 Jul 13;51(6):399-403.

18.

Use of topical colistin in multiple drug-resistant Pseudomonas aeruginosa bacterial keratitis.

Jain R, Murthy SI, Motukupally SR, Jain M.

Cornea. 2014 Sep;33(9):923-7. doi: 10.1097/ICO.0000000000000184.

PMID:
25014142
19.

Current diagnosis and treatment of corneal ulcers.

Benson WH, Lanier JD.

Curr Opin Ophthalmol. 1998 Aug;9(4):45-9. Review.

PMID:
10387468
20.

Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes.

Henry CR, Flynn HW Jr, Miller D, Forster RK, Alfonso EC.

Ophthalmology. 2012 Dec;119(12):2443-9. doi: 10.1016/j.ophtha.2012.06.030. Epub 2012 Aug 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk